Musculoskeletal Pain
📧 Sign up to get email alerts when something new happens for Musculoskeletal Pain.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-07-29FDA Approved: DULOXETINE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for duloxetine filed by Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2022-07-26FDA Approved: DULOXETINE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for DULOXETINE submitted by Quallent Pharmaceuticals Health LLC. The notice confirms regulatory …
-
FDA approval · 2022-07-15FDA Approved: METHOCARBAMOL — Supplemental Application (Trifluent Pharma LLC)
The FDA approved a supplemental application for Methocarbamol filed by Trifluent Pharma LLC. This action updates the regulatory status of Me…
-
CLINICAL_TRIALS trial_result · 2022-06-09Clinical Trial Update: Topical CBD for Musculoskeletal Pain [Phase 3]
Phase 3 clinical trial update evaluating topical CBD for musculoskeletal pain.
-
FDA approval · 2022-04-05FDA Approved: CHLORZOXAZONE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original application for chlorzoxazone (a generic muscle relaxant) from Rising Pharma Holdings, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-03-21Clinical Trial Update: Efficacy and Safety Study of Ibuprofen Gel Compared to Placebo in the Treatment of Acute Musculoskeletal Pain [Phase 3]
Phase 3 clinical trial evaluating ibuprofen gel versus placebo for acute musculoskeletal pain to assess efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2022-03-17Clinical Trial Update: Arnica and the Management of Pain in Acute Musculoskeletal Extremity Injuries [Phase 2, Phase 3]
Clinical trial update for Arnica in managing pain from acute musculoskeletal extremity injuries (Phase 2/Phase 3).
-
CLINICAL_TRIALS trial_result · 2022-02-01Clinical Trial Update: Comparing Five Oral Analgesics for Treatment of Acute Pain in the Emergency Department (ED) [Phase 2]
Phase 2 trial comparing five oral analgesics for acute musculoskeletal pain in the Emergency Department completed; results posted in 2022.
-
FDA approval · 2022-01-25FDA Approved: DULOXETINE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for a generic duloxetine hydrochloride product from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2021-11-10Clinical Trial Update: The MSK-Tracker Study [NA]
A completed clinical trial update for the MSK-Tracker Study investigating musculoskeletal pain; results have been posted.
-
FDA approval · 2021-10-20FDA Approved: CARISOPRODOL TABLETS, USP, 350 MG — Original Application (Granulation Technology, Inc.)
The FDA approved an original ANDA for Carisoprodol Tablets, USP, 350 mg, establishing a generic version of the muscle relaxant for short-ter…
-
CLINICAL_TRIALS trial_result · 2021-10-14Clinical Trial Update: The Effect of Low Level Laser Therapy on Neck and Shoulder Pain [NA]
Clinical trial evaluating low level laser therapy for neck and shoulder musculoskeletal pain has completed with posted results.
-
FDA approval · 2021-07-29FDA Approved: CHLORZOXAZONE — Original Application (Happy Robin, LLC)
FDA approved a generic chlorzoxazone product under an original ANDA from Happy Robin, LLC.
-
FDA approval · 2021-07-23FDA Approved: DRIZALMA SPRINKLE — Supplemental Application (SUN PHARMACEUTICAL INDUSTRIES, INC.)
The FDA approved a supplemental application for Drizalma Sprinkle, a duloxetine product, expanding the label to include a sprinkle-form dosa…
-
CLINICAL_TRIALS trial_result · 2021-07-15Clinical Trial Update: Implementation of Nurse-guided Web-based Cognitive Behavioral Therapy for Pain Management [NA]
The clinical trial evaluating nurse-guided web-based cognitive behavioral therapy for chronic musculoskeletal pain has completed, and its re…
-
CLINICAL_TRIALS research · 2021-06-09Clinical Trial Update: A Proactive Walking Trial to Reduce Pain in Black Veterans [NA]
A completed clinical trial evaluating a walking program to reduce musculoskeletal pain in Black veterans; results posted in 2021.
-
FDA approval · 2021-04-28FDA Approved: FLECTOR — Supplemental Application (IBSA Pharma Inc.)
FDA approved a supplemental application for FLECTOR (diclofenac epolamine) submitted by IBSA Pharma Inc.
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: Continous Popliteal Block for Microvascular Free Flap Reconstruction in Ear, Nose and Throat Surgery [Phase 4]
Phase 4 trial update on continuous popliteal block for microvascular free flap reconstruction in head and neck surgery; study completed.
-
CLINICAL_TRIALS trial_result · 2021-03-03Clinical Trial Update: Brief Cognitive Behavioral Therapy for Chronic Pain [NA]
Completed clinical trial evaluating Brief Cognitive Behavioral Therapy for Chronic Pain; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-02-24Clinical Trial Update: Efficacy and Safety of the Combination of Ketoprofen and Cyclobenzaprine in Osteomuscular Treatment [Phase 3]
Phase 3 trial update evaluating efficacy and safety of ketoprofen plus cyclobenzaprine in musculoskeletal pain shows completed status.
-
CLINICAL_TRIALS trial_result · 2021-02-04Clinical Trial Update: Low Dose Ketamine (LDK) Versus Morphine for Acute Pain Control in the Emergency Department [Phase 4]
A Phase 4 trial comparing low dose ketamine to morphine for acute pain control in the emergency department has completed with posted results…
-
FDA approval · 2020-12-30FDA Approved: DULOXETINE — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' supplemental application for duloxetine (ANDA204343), enabling the continued marketing of the gener…
-
FDA approval · 2020-08-12FDA Approved: METHOCARBAMOL — Original Application (Aurobindo Pharma Limited)
The FDA approved Aurobindo Pharma Limited's original application for methocarbamol, granting generic approval for this muscle relaxant. This…
-
FDA approval · 2020-07-21FDA Approved: CHLORZOXAZONE — Original Application (Mayne Pharma Commercial LLC)
FDA approved Mayne Pharma's original application for chlorzoxazone, a generic skeletal muscle relaxant indicated for relief of muscle spasm …
-
CLINICAL_TRIALS trial_result · 2020-07-08Clinical Trial Update: Altering The Transition From Acute to Chronic Pain (ATTAC-Pain) [Phase 2]
Phase 2 clinical trial update studying the transition from acute to chronic musculoskeletal pain (ATTAC-Pain).